Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights
May 09, 2024 08:30 ET
|
SofWave Medical, Ltd.
First quarter revenue of $13.2M, +27% year-over-year growth; IFRS gross margin of 75.2%First quarter pulse recurring revenue of $4.7M, +118% year-over-year growth IFRS and non-IFRS...
Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference
March 28, 2024 08:00 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide,...
Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
March 06, 2024 08:30 ET
|
SofWave Medical, Ltd.
– Full fiscal 2023 revenue of $50.3M, +41% year-over-year growth; gross margin of 74.5% – Full fiscal 2023 pulse recurring revenue of $13.0M, +81% year-over-year growth – Fourth quarter revenue...
Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting
March 04, 2024 08:30 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, is excited to...
Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
February 28, 2024 08:00 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer
February 12, 2024 08:30 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners...
Sofwave Medical Receives 510(k) Marketing Clearance for Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology
January 03, 2024 08:30 ET
|
SofWave Medical, Ltd.
Pure Impact™ with PlyoPulse™ technology is a direct add-on Body module to the existing FDA cleared Sofwave medical aesthetic device platformThe PlyoPulse™ technology is an EMS (Electrical Muscle...
Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm
December 26, 2023 08:30 ET
|
SofWave Medical, Ltd.
FDA clearance supported by highly compelling clinical study results demonstrating 93% of subjects treated arms were “improved” or “very much improved” in appearance, following treatment utilizing...
Sofwave Medical Reports Third Quarter 2023 Financial Results and Business Highlights
November 08, 2023 08:30 ET
|
SofWave Medical, Ltd.
- Third quarter revenue of $12.2M, +49% year-over-year growth- Third quarter pulse recurring revenue of $3.1M, +99% year-over-year growth- First nine months revenue of $35.0M, +60% year-over-year...
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Treatment of Acne Scars
August 30, 2023 08:30 ET
|
SofWave Medical, Ltd.
FDA clearance supported by a clinical study (n=67) and demonstrated treatment safety and efficacy utilizing SUPERB™, 97% of the treated participants in the trial showed improvement in the appearance...